ISSN: 2161-0460

Journal de la maladie d'Alzheimer et du parkinsonisme

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Clés académiques
  • JournalTOC
  • Infrastructure nationale du savoir de Chine (CNKI)
  • Bibliothèque de revues électroniques
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Bibliothèque virtuelle de biologie (vifabio)
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

MIBG Cardiac Imaging is Less Promising in Differentiating PD from Other Parkinsonism for Early-Onset Patients

Wenjia Zhu, Dan Xu, Li Huo and Han Wang

Objective: Age at onset has an impact on cardiac meta-iodobenzylguanidine (MIBG) uptake in Parkinson’s disease (PD), but not in other parkinsonism. In the present study, we hypothesized that there is an interaction between age at onset and disease group for heart-to-mediastinum (H/M) ratios.

Methods: Ninety-two patients with parkinsonism, including 60 patients with PD and 32 patients with other neurodegenerative parkinsonism, were retrospectively reviewed. Patients were grouped into the early-onset group (age at onset ≤50 y/o) and late-onset group (age at onset >50 y/o) according to the time they first developed motor symptoms. 131I-MIBG cardiac scintigraphy was done and heart-to-mediastinum ratio was used to quantify cardiac uptake.

Results: There was a statistically significant interaction between disease group and age at onset for both early (P=0.008) and delayed H/M ratio (P=0.043). Subgroup analysis demonstrated that no significant difference was found between PD and other neurodegenerative parkinsonism in the early-onset group for either early (2.03 ± 0.42 vs. 2.01 ± 0.29, P=0.882) or delayed H/M ratio (2.05 ± 0.56 vs. 2.22 ± 0.52, P=0.468). In patients with PD, there was significant difference in H/M ratio for both early (P=0.004) and delayed scan (P=0.002) between early-onset and lateonset patients. In patients with other neurodegenerative parkinsonism, no significant difference was found in H/M ratio for either early (P=0.314) or delayed scan (P=0.902) between early-onset and late-onset patients. Using ROC analysis, H/M ratio can be used to differentiate PD from other neurodegenerative parkinsonism (AUC=0.749 and 0.784 for early and delayed scan, respectively). By deselecting early-onset patients, the discrimination power can be further improved (AUC=0.812 and 0.824 for early and delayed scan, respectively) in late-onset patients.

Conclusion: There is an interaction between age at onset and disease group for H/M ratios. 131I-MIBG cardiac sympathetic imaging is less promising in differentiating PD from other parkinsonism for early-onset patients.